Greenbank Capital and Pharmakure Mutually Agree to Termination of Exsiting Agreement and Are Discussing Fresh Terms
Greenbank Capital and Pharmakure Mutually Agree to Termination of Exsiting Agreement and Are Discussing Fresh Terms
TORONTO, ON / ACCESSWIRE / November 1, 2021 / GreenBank Capital Inc. (CSE:GBC)(OTC PINK:GRNBF)(FRA:2TL) ("GreenBank" or "the Company") announces that Pharmakure Limited ("Pharmakure") and the Company have mutually agreed to terminate their previously disclosed commercial agreement ("The Agreement") in which GreenBank was to acquire a shareholding in and provide merchant banking services to Pharmakure and now are currently discussing new terms.
多倫多，於/ACCESSWIRE/2021年11月1日/亞洲網加利福尼亞州聖何塞10月24日電Greenbank Capital Inc.(CSE：GBC)(場外交易代碼：GRNBF)(法蘭克福機場股票代碼：2TL)(以下簡稱“Greenbank”或“本公司”)宣佈，PharmaKure Limited(“PharmaKure”)和本公司已共同同意終止其先前披露的商業協議(“該協議”)，根據該協議，Greenbank將持有PharmaKure的股份並向PharmaKure提供商業銀行服務，目前正在討論新的條款。
In the meantime both parties agree that there are no further accrued rights, entitlements, obligations, or funding requirements under the Agreement by either Pharmakure or GreenBank, that all costs incurred to date by either company are for their own account, and that the $50,000 CAD sum paid by Pharmakure to GreenBank in May of 2021 is a non-reimbursable payment for work performed. The Confidentiality provisions of the Agreement shall remain in force and effect for a period of two years.
與此同時，雙方同意，根據協議，PharmaKure或Greenbank不再有任何應計權利、權利、義務或資金要求，兩家公司迄今發生的所有成本都由它們自己承擔，PharmaKure於2021年5月向Greenbank支付的50,000加元是對所完成工作的不可報銷付款。本協定的保密條款的效力和效力為兩年。
GreenBank remains excited about and interested in Pharmakure' s ambitious aims and goals in respect to treating the symptoms of Alzheimer's Disease and remain impressed with Pharmakure's progress to date as well as the professionalism and competence of their management team. The two companies are currently discussing new ways in which GreenBank can assist Pharmakure's intensive plans and have concluded that such arrangements would necessitate a new agreement.
Greenbank仍然對PharmaKure在治療阿爾茨海默氏症症狀方面的雄心勃勃的目標和目標感到興奮和感興趣，並對PharmaKure迄今取得的進展以及他們管理團隊的專業精神和能力留下了深刻印象。這兩家公司目前正在討論Greenbank幫助PharmaKure的密集計劃的新方式，並得出結論，這種安排將需要一項新的協議。
About GreenBank
關於Greenbank
GreenBank is a next generation merchant banking business that has a flexible low-cost overhead structure designed to maximize profitability. Our management are based in Toronto, Dallas and London and are used to working across borders remotely. Our model of remote working, dynamic space and flexible contracts -rather than large fixed costs - establishes GreenBank as a global merchant bank for the future, both during and after COVID19.
Greenbank是下一代商業銀行業務，具有靈活的低成本管理結構，旨在最大化盈利能力。我們的管理層總部設在多倫多、達拉斯和倫敦，習慣於跨境遠程工作。我們的遠程工作模式、動態空間和靈活的合同--而不是大量的固定成本--使Greenbank成為未來的全球商業銀行，無論是在COVID19期間還是之後。
GreenBank is listed on the Canadian Securities Exchange, the Frankfurt Boerse and on the OTC Markets in the USA. GreenBank invests in undervalued exponential growth companies focused on building consistent capital appreciation for its shareholders. For details of our "6 Key Drivers of Value" please see our latest Investor Presentation:
Greenbank在加拿大證券交易所、法蘭克福證券交易所和美國場外交易市場上市。Greenbank投資於被低估的指數成長型公司，專注於為其股東建立持續的資本增值。有關我們的“六大關鍵價值驅動因素”的詳細信息，請參閲我們最新的投資者演示文稿：
https://greenbankcapitalinc.com/wp-content/uploads/2020/11/03.11.20_Greenbank-Deck-compressed.pdf
Https://greenbankcapitalinc.com/wp-content/uploads/2020/11/03.11.20_Greenbank-Deck-compressed.pdf
For more information please visit our website www.GreenBankCapitalInc.com or contact
欲瞭解更多信息，請訪問我們的網站www.GreenBankCapitalInc.com或聯繫
Mark Wettreich at +1 (214) 202-4353 or by email Mark@GreenBankCapitalinc.com
Mark Wettreich電話：+1(214)202-4353或電子郵件Mark@GreenBankCapitalinc.com
SOURCE: GreenBank Capital Inc.
資料來源：Greenbank Capital Inc.
譯文內容由第三人軟體翻譯。